stdClass Object ( [id] => 17997 [paper_index] => 202510-01-024697 [title] => EVIDENCE BASED OUTCOMES OF RASAYANA THERAPIES FOR MILD COGNITIVE IMPAIRMENT IN THE ELDERLY: A NARRATIVE REVIEW [description] => [author] => Dr. Sinsha.A.S, Dr. Midhila.K.J [googlescholar] => [doi] => https://doi.org/10.36713/epra24697 [year] => 2025 [month] => October [volume] => 11 [issue] => 10 [file] => fm/jpanel/upload/2025/November/202510-01-024697.pdf [abstract] => Mild cognitive impairment (MCI) is a prevalent age-related health concern that signifies a transitional phase between normal cognitive aging and early dementia, with Ayurveda correlating it to Jarajanya Smrthibramsa linked to aging and aggravated Vāta Doṣa. Its prevalence increases with age, affecting up to 25.2% of individuals aged 80-84. While early detection and interventions are essential, FDA-approved pharmacological treatments remain lacking. Ayurvedic modalities such as Rasāyana therapies can provide a viable strategy for managing MCI. In this narrative review, studies investigating the effects of Rasāyana on MCI were evaluated. A broad search strategy was employed using several online databases, covering articles from January 2000 to July 2024, resulting in the assessment of 23 articles. Evidence-based studies in Rasāyana therapy have examined improvements in nutritional quality, cerebral metabolism, and microcirculation, all of which support neuroprotection and cognitive function. This review underscores the direct and indirect roles of Ayurveda Rasāyana in the management and prevention of MCI. [keywords] => Mild Cognitive Impairment, Jarajanya Smrthibramsa, Rasāyana [doj] => 2025-11-03 [hit] => [status] => [award_status] => P [orderr] => 126 [journal_id] => 1 [googlesearch_link] => [edit_on] => [is_status] => 1 [journalname] => EPRA International Journal of Multidisciplinary Research (IJMR) [short_code] => IJMR [eissn] => 2455-3662 (Online) [pissn] => - -- [home_page_wrapper] => images/products_image/11.IJMR.png ) Error fetching PDF file.